ScholarIQanswers from OpenAlex

β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease

PaperCitations, authors & open-access status

β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease have?

ScholarIQcitation count

β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease has 11 citations in the OpenAlex counts ScholarIQ stores.

When was β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease published?

ScholarIQyear

β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease has 2024 year in the ScholarIQ index.

What is the open-access status of β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease?

ScholarIQoa status

β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease has gold oa status in the ScholarIQ index.

What is the DOI of β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease?

ScholarIQdoi

The DOI for β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease is on the source record.

What is the PMID of β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease?

ScholarIQpmid

The PMID for β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease is on the source record.

What is the OpenAlex record for β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease?

ScholarIQopenalex

The OpenAlex for β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial